MedEquities Realty Trust Inc (MRT) Director Sold $1,115,331.60 in Shares

MedEquities Realty Trust Inc (MRT) Director Sold $1,115,331.60 in Shares

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 102,324 shares of the business’s stock in a transaction that occurred on Thursday, January 17th. The stock was sold at an average price of $10.90, for a total transaction of $1,115,331.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Bluemountain Capital Managemen also recently made the following trade(s):

On Wednesday, January 30th, Bluemountain Capital Managemen sold 216,902 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $11.31, for a total transaction of $2,453,161.62.

On Monday, January 28th, Bluemountain Capital Managemen sold 134,126 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $11.13, for a total transaction of $1,492,822.38.

On Thursday, January 24th, Bluemountain Capital Managemen sold 362,699 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.94, for a total transaction of $3,967,927.06.

On Tuesday, January 22nd, Bluemountain Capital Managemen sold 83,411 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.84, for a total transaction of $904,175.24.

On Tuesday, January 15th, Bluemountain Capital Managemen sold 210,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.65, for a total transaction of $2,236,500.00.

On Friday, January 11th, Bluemountain Capital Managemen sold 255,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.56, for a total transaction of $2,692,800.00.

On Thursday, December 6th, Bluemountain Capital Managemen sold 4,617 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $6.67, for a total transaction of $30,795.39.

On Monday, December 3rd, Bluemountain Capital Managemen sold 10,342 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $6.90, for a total transaction of $71,359.80.

On Friday, November 30th, Bluemountain Capital Managemen sold 29,051 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $6.99, for a total transaction of $203,066.49.

On Wednesday, November 28th, Bluemountain Capital Managemen sold 21,601 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $7.05, for a total transaction of $152,287.05.

Shares of MRT stock traded up $0.03 during mid-day trading on Monday, reaching $11.44. 305,483 shares of the company’s stock traded hands, compared to its average volume of 991,218. MedEquities Realty Trust Inc has a 12 month low of $6.27 and a 12 month high of $11.85. The company has a market cap of $363.55 million, a price-to-earnings ratio of 10.04 and a beta of 1.79.

MedEquities Realty Trust (NYSE:MRT) last issued its quarterly earnings data on Monday, November 12th. The financial services provider reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.25). MedEquities Realty Trust had a net margin of 19.98% and a return on equity of 3.39%. The business had revenue of $9.68 million for the quarter, compared to the consensus estimate of $17.72 million. As a group, sell-side analysts expect that MedEquities Realty Trust Inc will post 0.8 earnings per share for the current fiscal year.

Several hedge funds have recently modified their holdings of MRT. Schwab Charles Investment Management Inc. lifted its stake in shares of MedEquities Realty Trust by 0.7% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 764,932 shares of the financial services provider’s stock valued at $8,430,000 after buying an additional 5,106 shares in the last quarter. BlackRock Inc. lifted its stake in shares of MedEquities Realty Trust by 5.5% during the 2nd quarter. BlackRock Inc. now owns 1,499,494 shares of the financial services provider’s stock valued at $16,526,000 after buying an additional 77,884 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of MedEquities Realty Trust by 23.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 92,794 shares of the financial services provider’s stock valued at $1,023,000 after buying an additional 17,862 shares in the last quarter. Citadel Advisors LLC lifted its stake in shares of MedEquities Realty Trust by 82.0% during the 2nd quarter. Citadel Advisors LLC now owns 29,486 shares of the financial services provider’s stock valued at $325,000 after buying an additional 13,284 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its stake in shares of MedEquities Realty Trust by 36.0% during the 2nd quarter. Renaissance Technologies LLC now owns 839,800 shares of the financial services provider’s stock valued at $9,255,000 after buying an additional 222,500 shares in the last quarter. 91.77% of the stock is owned by hedge funds and other institutional investors.

A number of equities research analysts have commented on MRT shares. JMP Securities set a $12.00 target price on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a research report on Tuesday, October 23rd. Citigroup raised shares of MedEquities Realty Trust from a “sell” rating to a “neutral” rating and set a $9.00 target price for the company in a research report on Monday, November 12th. B. Riley cut their target price on shares of MedEquities Realty Trust from $12.00 to $11.00 and set a “buy” rating for the company in a research report on Tuesday, November 13th. Raymond James cut their target price on shares of MedEquities Realty Trust from $12.00 to $10.00 and set a “buy” rating for the company in a research report on Tuesday, November 20th. Finally, Zacks Investment Research downgraded shares of MedEquities Realty Trust from a “hold” rating to a “sell” rating in a research report on Friday, November 23rd. Nine research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $10.89.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Featured Story: Is it better to buy a fund with a higher or lower NAV?

Related posts

Leave a Comment